{"id":"W4249533637","doi":"10.15562/bdv.v3i2.38","title":"Focus on the dabrafenib, vemurafenib, and trametinib in clinical outcome of melanoma: a systematic review and meta-analysis","year":2020,"lang":"en","type":"review","venue":"Bali Dermatology and Venereology Journal","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Trametinib; Dabrafenib; Vemurafenib; Medicine; Oncology; Internal medicine; Melanoma; MEK inhibitor; Targeted therapy; Randomized controlled trial; Meta-analysis; Cancer; Cancer research; Metastatic melanoma; MAPK/ERK pathway","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01575955,0.003018727,0.01943165,0.008432922,0.0006782024,0.003599018,0.002214914,0.002195362,0.004516856],"category_scores_gemma":[0.03489322,0.001174573,0.04018053,0.009596531,0.0007122267,0.002093075,0.001694514,0.001802485,0.0003235549],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003281373,"about_ca_system_score_gemma":0.005649399,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.009239283,"about_ca_topic_score_gemma":0.02220062,"domain_scores_codex":[0.9892196,0.004658224,0.003350738,0.001086374,0.00129456,0.0003904924],"domain_scores_gemma":[0.976824,0.01707805,0.003487553,0.0004939288,0.001818652,0.0002977447],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.0009205907,0.00002030361,0.003389616,0.5946163,0.3899825,0.0001282835,0.00008856005,0.0003422246,0.0001515015,0.0001732804,0.0006780803,0.009508756],"study_design_scores_gemma":[0.0002822956,0.000123981,0.003281178,0.05478493,0.9388446,0.0001195072,0.00006290372,0.0001244756,0.00008486705,0.0001936086,0.00207616,0.00002147081],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001990083,0.9967186,0.0002499969,0.0002040645,0.00008430424,0.0001558398,0.0004137649,0.00001233494,0.0001709764],"genre_scores_gemma":[0.1056078,0.8898274,0.001243415,0.0010217,0.000217598,0.0009206916,0.0008154199,0.00002966267,0.0003162477],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01943165,"threshold_uncertainty_score":0.08334541,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.10863957499082,"score_gpt":0.3745808384374596,"score_spread":0.2659412634466395,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}